Health Care/Hospital
CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China
* CBC Group and Mubadala acquire UCB's mature neurology and allergy business inChina for US$680 million. * New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry. * Strategic acquisition under CBC's buyout strategy exp...
2024-11-30 09:00
1606
Life-Space Wins Prestigious 62nd Australian Export Awards
MELBOURNE, Australia, Nov. 29, 2024 /PRNewswire/ -- At the prestigious 62nd Australian Export Awards held at Parliament House in Canberra, Life-Space, Australia's No. 1 probiotic brand, proudly claimed the title of 'E-commerce Winner of the Australian Export Awards 2024'. This incredible achievem...
2024-11-29 16:00
1068
"Are your Hands & Feet trying to tell you something?" - Ask leading Health Experts
* Do you feel numbness, pain, tingling or pins and needles in your hands and feet? * 8 out of 10 patients with Peripheral Neuropathy don't listen to what their nerves are telling them and go undiagnosed leading to worsening of symptoms. MANILA, Philippines, Nov. 29, 2024 /PRNewswire/ -- As pa...
2024-11-29 13:30
1162
2024 Global Youth Powerhouse Summit in Hong Kong: Global Leaders and Young Professionals Address Innovation and Economic Development
Key Highlights: * The inaugural Global Youth Powerhouse Summit 2024 is under way at the Hong Kong Maritime Museum, bringing together a dynamic community of young professionals, government leaders and C-suite-level management. With over 200 local and international participants attending in pers...
2024-11-29 13:02
1049
Ping An Wins Sixth Director of the Year Award and Inaugural Climate Governance Award from the Hong Kong Institute of Directors
HONG KONG and SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318/82318, SSE: 601318) received the Director of the Year Award and the Climate Governance Award for 2024 from the Hong Kong Institute of Directors (HK...
2024-11-29 10:56
1722
Borsch Med Partners with Unity Pharmacies to Help Elderly Access Zeria Chondroitin-based Joint Health Supplements in Support of Healthy Ageing in Singapore
SINGAPORE, Nov. 29, 2024 /PRNewswire/ -- Leading health and nutrition company, Borsch Med Pte Ltd (Borch Med) has announced that Zeria chrondroitin-based joint health supplements are now available at selected Unity pharmacies in Singapore. The enhanced distribution network of the Japanese-made sup...
2024-11-29 10:00
1257
Microbio Appoints Paul Brennan as Chair of the Board
BRISBANE, Australia, Nov. 29, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has appointedPaul Brennan as Chair of the Board, effective 2nd December 2024. Paul brings extensive global experience as a Non-E...
2024-11-29 06:30
1322
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific...
2024-11-28 21:30
2415
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
MELBOURNE, Australia, Nov. 28, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma) today announce that a first patient has been dosed in the Phase III ZIRCON-CP trial of TLX250-CDx positron ...
2024-11-28 17:22
1604
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List
ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the new indication...
2024-11-28 16:59
1553
Own Your Story with AwarerHOME™
Malaysia's HIV Oral Self-Test for Accessible and Confident Testing KUALA LUMPUR, Malaysia, Nov. 28, 2024 /PRNewswire/ -- Say hello to confidence and control with AwarerHOME™,Malaysia's first homegrown HIV Oral Self-Test. This accessible, no-mess, no-fuss solution offers something even more impor...
2024-11-28 16:34
1146
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List
SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that NEFECON® has been included in the...
2024-11-28 13:43
1368
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country
SHANGHAI and HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hema...
2024-11-28 13:04
1483
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
2024-11-28 12:07
1678
Dr. Robert Yap Honoured with World Chinese Distinguished Entrepreneur Lifetime Achievement Award at GCET 2024
PHNOM PENH, Cambodia, Nov. 28, 2024 /PRNewswire/ -- Dr Robert Yap, Executive Chairman of YCH Group, has been awarded the 2024 World Chinese Distinguished Entrepreneur Lifetime Achievement Award at the Global Chinese Economic & Technology Summit (GCET 2024) inPhnom Penh, Cambodia. This prestigious...
2024-11-28 10:39
1454
Newbase Launches 'Medicrew', a VR Medical Training Platform to Accelerate Global Market Expansion
Participation in IMSH 2025 to Showcase Innovations in Medical Education
SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ -- Newbase
2024-11-28 09:00
1280
Prenetics Announces Third Quarter 2024 Financial Results
Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta's Early Cancer Detection Reiterates Revenue Target to Exceed $33 million for FY 2024 CHARLOTTE, N.C., Nov. 27, 2024 /P...
2024-11-27 21:30
2328
Everest Medicines to Hold Investor Calls on Data Results from EVER001 Phase 1b/2a Clinical Study in Primary Membranous Nephropathy
SHANGHAI, Nov. 27, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will hold investor calls on t...
2024-11-27 19:08
2369
Tanoto Foundation Enhances Students' Literacy and Numeracy Through Early Childhood and Basic Education Interventions
SINGAPORE, Nov. 27, 2024 /PRNewswire/ -- The 2022 Programme for International Student Assessment (PISA) survey revealed concerning results for Indonesian students, with low rankings in literacy and numeracy.Indonesia's performance, which declined by 12-13 points in reading, mathematics, and scien...
2024-11-27 16:43
1375
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC
CHENGDU, China, Nov. 27, 2024 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization inChina from National Medical Products Administration (NMPA) for the first domestically developed trophoblast cell-surface an...
2024-11-27 14:34
1693
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 275 media titles]
2024-11-29 20:33
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
14553
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
10661
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8491
